FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to therapy of topical suppurative-inflammatory processes. Agent represents an aqueous isoosmotic solution comprising 0.25% of novocaine, 1% of cefazolin sodium salt and 0.77% of sodium chloride. Invention provides the development of optimal conditions for safety mechanical moving of agent in intercellular space under positive hydrodynamic pressure in the permanent state from the injection point in direction to side of deeply localized pathological focus and eliminates the pain component of the inflammatory response.
EFFECT: valuable medicinal properties of agent.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOFT TISSUE INJECTION METHOD | 2007 |
|
RU2328318C1 |
| METHOD FOR TESTING THE QUALITY OF MEDICINAL PREPARATIONS | 2005 |
|
RU2304769C2 |
| METHOD INCREASING SAFETY OF INJECTIONS | 2007 |
|
RU2340361C1 |
| METHOD OF POSTINJECTION NECROSIS PREVENTION | 2006 |
|
RU2326662C1 |
| ANTI-ADHESION MEANS | 2016 |
|
RU2645074C2 |
| METHOD OF INCREASING POSTINJECTION SAFETY OF MEDICINES AT REPEATED INTRAMUSCULAR INJECTIONS | 2007 |
|
RU2350358C2 |
| METHOD FOR DETECTING DRUG-MEDIATED SOLUTION IATROGENESIS IN HOSPITAL DEATH CASES | 2001 |
|
RU2204324C2 |
| METHOD OF FUNICULAR ANESTHESIA | 2010 |
|
RU2422164C1 |
| METHOD FOR MEDICINAL FINGER INFILTRATION | 2005 |
|
RU2304930C1 |
| BLEACHING AGENT | 2014 |
|
RU2589682C1 |
